June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Global Analysis of DNA Methylation Changes in Fuchs Endothelial Corneal Dystrophy
Author Affiliations & Notes
  • Emily Khuc
    Department of Ophthalmology, UCSF Medical School, San Francisco, CA
  • Russell Bainer
    Department of Surgery, UCSF Medical School, San Francisco, CA
  • Marie Wolf
    Department of Ophthalmology, UCSF Medical School, San Francisco, CA
  • Jacquelyn Kemmer
    Department of Ophthalmology, UCSF Medical School, San Francisco, CA
  • Valerie Weaver
    Department of Surgery, UCSF Medical School, San Francisco, CA
    Department of Bioengineering and Therapeutic Sciences, UCSF Medical School, San Francisco, CA
  • David Hwang
    Department of Ophthalmology, UCSF Medical School, San Francisco, CA
  • Matilda F Chan
    Department of Ophthalmology, UCSF Medical School, San Francisco, CA
    Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, CA
  • Footnotes
    Commercial Relationships Emily Khuc, None; Russell Bainer, None; Marie Wolf, None; Jacquelyn Kemmer, None; Valerie Weaver, None; David Hwang, None; Matilda Chan, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2522. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emily Khuc, Russell Bainer, Marie Wolf, Jacquelyn Kemmer, Valerie Weaver, David Hwang, Matilda F Chan; Global Analysis of DNA Methylation Changes in Fuchs Endothelial Corneal Dystrophy. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2522.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Fuchs endothelial corneal dystrophy (FECD) is the most common indication for corneal transplantation in the United States. While genetic analyses have linked a single chromosomal locus to the early onset form of FECD, the genetic determinants of the more common, late onset form are not fully understood. Recent data has demonstrated that aberrant epigenetic modifications lead to various disease processes including inherited syndromes, cancer, and fibrosis. We tested the hypothesis that DNA methylation changes in the corneal endothelial tissue of patients correlate with late onset FECD.

Methods: Total DNA was extracted from 4 FECD endothelial samples retrieved from patients undergoing endothelial keratoplasty due to clinically diagnosed end-stage FECD and from 2 normal endothelial samples obtained from an eye bank. The Illumina Infinium Methylation 450k assay was used to perform global methylation analysis of over 485,000 methylation sites annotated to the coding and noncoding regions of over 99% RefSeq genes. We compared methylation profiles of a single FECD patient sample and of a sample pool derived from 3 FECD patients to contrast individual patient changes with broader population-level alterations. Beta values derived from the arrays were analyzed in R and Microsoft Excel.

Results: The correlation structure of the patient data was consistent with the experimental variables, such that the single FECD patient clustered away from the normal and pooled samples. The FECD samples were generally hypermethylated relative to the normal controls in those sites in which methylation levels differ between FECD and normal patient samples. The 50 most highly methylated sites were annotated to genes involved in cell migration, cytoskeletal reorganization, and ion transport. Sites within TCF4, a gene previously shown to be significantly associated with FECD, were also hypermethylated in the FECD samples compared to the control samples.

Conclusions: Global hypermethylation changes appear to occur in FECD and may result in the decreased expression of genes involved in cell migration, cytoskeletal reorganization, and ion transport. DNA methylation changes result in altered gene expression patterns in several human diseases, and our results suggest that altered DNA methylation patterns may likewise contribute to the etiology of late-onset FECD.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×